Latest Topiramate Stories
Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from
Upsher-Smith-sponsored data to include the first presentation of pooled Phase 1 data on the adverse event profile of USL255 (Qudexy(TM) XR (topiramate) extended-release capsules) MAPLE GROVE,
A pharmaceutical product liability litigation firm, Carey Danis & Lowe announced that they have launched an investigation into alleged Topamax related injuries following news that a Philadelphia
Flood Law Group today announced that they are available to investigate claims of birth defects such as cleft palates or cleft lips that could be related to the use of the prescription drug Topamax
Matthews & Associates says manufacturer ignored red flags about drug's dangers PHILADELPHIA, March 14, 2014 /PRNewswire/ -- A Houston-based plaintiffs firm specializing in drug injury
Qudexy(TM) XR Offers Newest Option for Managing Certain Seizure Disorders and Marks the Company's Entrance into the Epilepsy Therapeutic Area MAPLE GROVE, Minn., March 12, 2014 /PRNewswire/
Last week a Philadelphia jury awarded $3 million in damages to the family of a 5 year-old who suffered birth defects allegedly caused by the mother's ingestion of Topamax during pregnancy.
Court Finds Janssen Pharmaceuticals' Drug Topamax Caused Child's Cleft Palate ALTON, Ill., March 10, 2014 /PRNewswire/ -- A jury last week awarded a $3 million verdict to the family
http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news.
Aid in Recovery, a full service drug and alcohol treatment center for substance abuse in South Florida, released a statement today commenting on new research that suggests that the seizure drug
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).